entertainment -WSS

entertainment

author：hotspot 2025-09-28 02:47:46 - browse：29549

A phone screen displays the webpage of Medicare.gov — coverage from STAT — Adobe

Over the past few weeks, Medicare Advantage insurers demanded that the Biden administration give them higher payment rates for next year. The government’s data on how much people were using health care didn’t match their own data, insurers and lobbyists griped — and therefore they wouldn’t be paid enough to cover those costs.

But the federal government was not persuaded by the industry’s data or lobbying push. The Biden administration and its Medicare agency decided to stick with their proposals from January on Monday, dealing a blow to an insurance industry that has come to rely on Medicare Advantage for a steady stream of profits.

The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% to the baseline payment rates that insurers receive from the government for enrolling older adults and people with disabilities. The stock prices of the largest Medicare Advantage insurers — UnitedHealth, Humana, CVS Health, and Elevance Health — all fell by at least 4% in after-hours trading.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

focus

WSS

Four alarming medical procedures we’re glad history forgot

Insurer loopholes limit power of law against surprise medical bills

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Hundreds died while taking an arthritis drug, but nobody alerted patients

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Sickle cell gene therapy cures need to be accessible in Africa

focus

entertainment

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

One Duchenne patient's bittersweet hope for new treatment

How one medical school became remarkably diverse

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

What does generative AI mean for health care? We asked experts

Drug companies' payments and gifts affect physicians' prescribing

Wildfire smoke exposes gaps in outdoor worker protections

Florida Supreme Court upholds state's abortion ban

Malaria cases in Florida and Texas: Here’s what you need to know

Digital health funding stays low as a new reality sets in

hotspot

Superbugs, antibiotic resistance get scrutiny in congress

Researchers test human milk's ability to repair gut microbiome

Digital health funding stays low as a new reality sets in

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Britney Spears to release memoir, 'The Woman In Me,' later this year

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

leisure time

leisure time

focus

entertainment